BICNU DIN 00297763
Health Canada record
| Active ingredient(s) | CARMUSTINE 100 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AD01 CARMUSTINE |
| Original market date | 31-Dec-1975 |
| Current status date | 19-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CARMUSTINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02531879 | CARMUSTINE FOR INJECTION USP | STERIMAX INC | Powder For Solution | CARMUSTINE 100 MG | Marketed |
| 02555093 | BICNU | MARCAN PHARMACEUTICALS INC | Solution | CARMUSTINE 100 MG | Cancelled Post Market |
| 02238985 | GLIADEL WAFER | EISAI LIMITED | Wafer | CARMUSTINE 7.7 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19829 | 2017-09-19 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 15217 | 2014-02-07 | New Drug Submission (NDS) | TRANSFER OF DRUG IDNETIFICATION NUMBERS |
| 7350 | 2005-09-02 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for CARMUSTINE
7 valid EDQM Certificates of Suitability from 7 holders. 12 active FDA Drug Master Files.
Request a quote for BICNU